Fight for Sight to fund macular degeneration research
As it stands, damage to the macula can’t be reversed, making it the most common cause of permanent and severe sight loss in the UK.
21st January 2020
-
Bag to the future
For decades intrepid pharma sales forces navigated the road network of Great Britain with little more than paper, pen and personality – hoping that one day the tools of their trade would mirror the cutting-edge science of the products they showcased. In recent years, the digital era has truly arrived, but as 2020 looms, big challenges still remain
-
Smart People: Hilary Hutton-Squire
PharmaTimes talks to Hilary Hutton-Squire, vice president and general manager of Gilead Sciences in the UK and Ireland, about the importance of valuing medicines in the right way
-
Unlocking value
How can 2020 be the year that R&D really delivers value, people get real about data, and pharma starts to develop even better medicines?
News
View all
EU clears Roche’s Polivy for certain lymphomas
The drug has been approved in combination with bendamustine and MabThera.
21st January 2020
New scan could see active breast tumour regions in ‘real-time’
Breast cancer is the most common type of cancer in the UK, with around 55,000 new cases each year.
21st January 2020
EMA licenses Mayzent for MS
Novartis also expects NICE and SMC decisions in the first half of 2020.
21st January 2020
‘Weak antibiotic pipeline’ poses threat to AMR fight
Of the 60 products in development, very few seem to show benefit over existing treatments.
20th January 2020
Web Exclusives
View all
Trick or treat?
Comparing safety in pharmaceutical advertising
An effective training strategy for pharma
Cassie Walker considers the role of Certainty Based Marking in developing an effective training strategy for pharma employees
Understanding customer needs
Most biopharma marketing executives say they don’t know what clients want – it’s time to change that
Picking a winner
Duncan McKay considers whether the UK picked a winner in cell and gene therapy
Magazine
View more from the latest edition
Smart People: Hilary Hutton-Squire
PharmaTimes talks to Hilary Hutton-Squire, vice president and general manager of Gilead Sciences in the UK and Ireland, about the importance of valuing medicines in the right way
A clearer picture
Marni Hall and Nicola Stanislaus look at the growing role of real-world evidence
Raising the bar
A 2019 review has shown that the current system for detecting cancer is failing to reach its potential. Fujifilm’s Adrian Waller says we need a more tech-enabled and patient-centred approach
The year of no Brexit (again)
Political uncertainty became endemic during 2019, despite a lot of government planning
2019 – the return of the mega deal?
Globally mega deals continue to abound, domestically the mid-market and PE have been the core drivers of activity
Unlocking value
How can 2020 be the year that R&D really delivers value, people get real about data, and pharma starts to develop even better medicines?
Bag to the future
For decades intrepid pharma sales forces navigated the road network of Great Britain with little more than paper, pen and personality – hoping that one day the tools of their trade would mirror the cutting-edge science of the products they showcased. In recent years, the digital era has truly arrived, but as 2020 looms, big challenges still remain
Going for gold
Who emerged victorious at this year’s Marketer of the Year, Communications Team of the Year and Sales competitions?
Thought Leadership
View all
The Value Exchange
Simon Grime, of Wilmington Healthcare, explains the principles of exchanging value with customers to gain trust and consent
Continuity in a time of uncertainty
Tony Cordrey, vice president of European Strategic Operations Accord Healthcare, stresses the importance of ensuring consistency and continuity in medicines supply
Paving the way
Is Europe catching up (or pioneering the way) in digital therapeutics?
Once Upon A Time…
Emma Knott, associate director and head of Social Media at Publicis Resolute, says there’s power in pharma’s core narrative
Webinars
View allDesigning Pharma organisations for success
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
